Verily

By Dave Muoio 11:13 am January 22, 2020
Verily, the life sciences research subsidiary of Alphabet, has received FDA 510(k) clearance for an augmented version of its prescription Study Watch wearable that includes some form of arrhythmia monitoring. While specific details on the so-called “Study Watch With Irregular Pulse Monitor” are yet to be published alongside the agency’s premarket notification, the product has been classified as a...
By Jonah Comstock 09:49 am January 21, 2020
One of the biggest digital health success stories of the two decades is in the diabetes space, especially the continuous glucose monitor (or CGM). The first CGM was approved by the FDA in 1999, but in the last decade we've seen CGMs become smaller, longer lasting and more comfortable, and we've seen huge strides in datasharing as CGM-phone connectivity went from novelty to commodity.  Dexcom has...
By MobiHealthNews 03:09 pm January 16, 2020
The Digital Therapeutics Alliance, an industry group advocating for the adoption and understanding of evidence-based digital health treatments, has named its new Board of Directors. Representing handful of different digital therapeutics stakeholders, those named are set to hold their positions for a two-year period. Along with Megan Coder, the group’s executive director, the board consists of:...
By Dave Muoio 03:05 pm January 8, 2020
Dr. Vindell Washington, the head on the Office of the National Coordinator for Health IT from August 2016 to January 2017, is the latest to jump on board at Alphabet's Verily, according to tweets from fellow ONC vet-turned-Googler Dr. Karen DeSalvo, as well as from Verily’s communications lead. He comes directly from a position as Blue Cross and Blue Shield of Louisiana’s chief medical officer....
By Dave Muoio 05:01 pm December 13, 2019
It has been a tumultuous week in the realm of digital health partnerships. It started with word of Proteus Digital Health’s floundering business and failed investment round, which reports say was partially driven by cooling relations between the digital pill maker and its longtime patron Otsuka Pharmaceuticals. A few days later, Sanofi announced a company-wide strategy shift that found Onduo, its...

Photo by Carsten Koall/Getty Images

By MobiHealthNews 11:25 am December 13, 2019
It’s been a big year for Google’s parent company Alphabet. Once upon a time, Google’s role in the health world was chiefly associated with "Googling" symptoms, but much has changed for the Silicon Valley giant. This year Google made major moves in the health industry—making waves when it announced a plan to acquire Fitbit and even dipping into the EHR space by demoing a new search feature. ...
By Dave Muoio 03:48 pm December 10, 2019
Sanofi announced a major strategy shift today that will end the pharma’s diabetes and cardiovascular R&D efforts in favor of a reinvigorated focus on growing its immunology and vaccine businesses. Among the fallout of this new game plan is Onduo, the pharma’s diabetes management joint venture with Verily that the two companies invested $500 million into back in 2016, according to the company’...
By Laura Lovett 04:10 pm October 29, 2019
Life insurer John Hancock has unveiled a new wearable program dubbed Aspire aimed at helping its members with diabetes manage the condition. The program was born out of a partnership with Verily and digital diabetes care platform Onduo.  Users of the new platform can access diabetes coaching via Onduo’s virtual clinic. The program also has fiscal rewards. According to the company, members using...
By Laura Lovett 12:08 pm September 5, 2019
Alphabet’s life science branch Verily is teaming up with digital health startup iRhythm on a new initiative focused on creating screening, diagnosis and management tools for patients with atrial fibrillation.  The collaboration is specifically targeted at alerting patients with asymptomatic or silent atrial fibrillation about their condition. The goal is to develop products that not only identify...
By Laura Lovett 10:47 am July 31, 2019
Castlight Health is seeing some major change ups in leadership this week. Yesterday the digital health company announced that its current CEO John Doyle is stepping down as director. The company has tapped Maeve O’Meara as the company’s next CEO. Siobhan Nolan Mangini will also join as the company’s next president, and maintains her position as chief financial officer. "With the appointments of...